Victoza Liraglutide Injection wholesale Pre-Filled Pen – For Laboratory Research Use Only

Victoza Liraglutide Injection wholesale Pre-Filled Pen – For Laboratory Research Use Only

$2.00

Victoza Liraglutide Injection 18mg/3ml in a pre-filled pen, manufactured by Novo Nordisk. Approved under S20160004. For laboratory research use only. Supports wholesale and retail.?For wholesale prices, other specifications and uses, please consult our staff?

EMI starting from $0.00/month - View Plans
Compare
分类:

描述

Victoza, containing the active compound liraglutide, is a long-acting GLP-1 receptor agonist widely studied for its impact on glucose metabolism, insulin regulation, and obesity-related mechanisms. This 3ml pre-filled pen delivers 18mg of liraglutide, and is formulated by Novo Nordisk A/S (Denmark) under the NMPA registration number S20160004.

This research-use-only compound is frequently applied in studies on:

  • Type 2 diabetes mellitus pathophysiology

  • Appetite control and energy balance

  • GLP-1 mediated cardiovascular effects

  • Metabolic and endocrine dysfunction models

Note: This product is not intended for clinical, therapeutic, or veterinary use.


Victoza Liraglutide Product Specifications

Parameter Details
Product Name Victoza (Liraglutide Injection)
Generic Name Liraglutide
CAS Number 204656-20-2
Molecular Formula C172H265N43O51
Molecular Weight 3751.2 g/mol
Dosage Form Injection (pre-filled pen)
Strength 18mg per 3ml
Concentration 6mg/ml
Packaging 1 pre-filled pen per box (needle not included)
Approval Number S20160004 (China)
Product Code 86978997002256
Manufacturer Novo Nordisk A/S, Denmark
Storage Conditions Store at 2–8°C; protect from light and do not freeze
Intended Use For laboratory research only

Victoza Liraglutide Mechanism of Action & Research Applications

Liraglutide acts as a glucagon-like peptide-1 (GLP-1) receptor agonist, mimicking natural incretin hormones to stimulate insulin secretion and suppress glucagon in a glucose-dependent manner. Its extended half-life enables daily injection studies in rodents and other models.

Common research applications include:

  • Obesity and appetite regulation

  • Insulin signaling and glucose tolerance

  • Liver steatosis and nonalcoholic fatty liver disease (NAFLD)

  • Cardiovascular risk and endothelial function

  • Combination therapy with SGLT2 inhibitors, DPP-4 inhibitors, and metformin


Victoza Liraglutide Observed Side Effects in Research Models

  • Nausea and gastric motility disruption

  • Reduced food intake (hypophagia)

  • Delayed gastric emptying

  • Injection site redness or irritation

  • Transient hypoglycemia in combination studies


Victoza Liraglutide Safety & Handling

Use Restriction: Strictly for laboratory research use only. Not for human or veterinary administration.

Handling: Use personal protective equipment (gloves, lab coat). Handle under aseptic conditions.

Storage: Store refrigerated (2–8°C). Avoid direct light and do not freeze.

Disposal: Dispose of contents and containers in accordance with local regulations and institutional biosafety procedures.


Research Use Disclaimer

This product is provided solely for use in laboratory research settings. It is not intended for human, veterinary, or diagnostic applications. Improper use may result in safety or legal consequences. Always follow institutional safety procedures.

其他信息

重量 1 公斤
尺寸 36 × 23 × 36 厘米

评价

目前还没有评价

成为第一个“Victoza Liraglutide Injection wholesale Pre-Filled Pen – For Laboratory Research Use Only” 的评价者

您的邮箱地址不会被公开。 必填项已用 * 标注

Q1: Is this Victoza pen intended for medical use?

A1: No. This is a research-use-only formulation and is not approved for therapeutic administration.

Q2: Is it the same liraglutide as in clinical use?

A2: Yes, it contains the same active ingredient, but this version is only for experimental and laboratory purposes.

Q3: Can I order in wholesale quantities?

A3: Yes. Wholesale and retail orders are supported. Please contact us for pricing and logistics.

Q4: Are documents like COA and SDS provided?

A4: Yes, Certificate of Analysis (COA) and Safety Data Sheet (SDS) are available upon request.

Q5: How is this product shipped?

A5: The pre-filled pen is shipped under cold-chain conditions to maintain product integrity.

Q6: Is Victoza used in weight-loss research?

A6: Yes, it is frequently studied for its effects on appetite regulation and body weight reduction.

Q7: Is this equivalent to Saxenda?

A7: Both Victoza and Saxenda contain liraglutide, but Saxenda is typically dosed higher for obesity, while Victoza is for glucose metabolism studies.

Q8: What species are used in liraglutide experiments?

A8: Commonly in mouse, rat, and non-human primate models, especially in obesity and insulin resistance research.

Q9: Can this be combined with other compounds?

A9: Yes. Liraglutide is often studied in combination with metformin, SGLT2 inhibitors, or dietary interventions.

Q10: Does it come with a needle?

A10: No, this pre-filled pen does not include a needle.


EMI Options

Select at least 2 products
to compare